Exploratory evaluation of the effect of cholestyramine on serum levels of persistent organic pollutants in obese patients

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505116-37-00

Acronym

21-AOI-07

Enrollment

Registered

2023-06-14

Start date

2024-02-08

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

Serum concentration of persistent organic pollutants between M0 (pre-surgery) and M4 (post-surgery)

Detailed description

Measurement of serum concentrations of persistants organics pollutants by mass spectrometry after bariatric surgery and determination of their evolution in relation to expected release.

Interventions

DRUGQUESTRAN 4 g

DRUGpoudre orale en sachet

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Serum concentration of persistent organic pollutants between M0 (pre-surgery) and M4 (post-surgery)	—

Secondary

Measure	Time frame
Measurement of serum concentrations of persistants organics pollutants by mass spectrometry after bariatric surgery and determination of their evolution in relation to expected release.	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026